Robert A Burger Selected Research

Robert A Burger Research Topics

Disease

51	Neoplasms (Cancer) 02/2024 - 03/2002
40	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 09/2003
22	Ovarian Epithelial Carcinoma 09/2023 - 09/2003
20	Carcinoma (Carcinomatosis) 12/2019 - 11/2002
13	Disease Progression 02/2024 - 07/2004
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2017 - 09/2003
6	Hypertension (High Blood Pressure) 07/2021 - 11/2007
5	Endometrial Neoplasms (Endometrial Cancer) 09/2020 - 10/2003
4	Ascites 12/2019 - 12/2008
2	Proteinuria 07/2021 - 11/2007
2	Residual Neoplasm 12/2019 - 03/2009
2	Hemorrhage 10/2017 - 11/2007
2	Fistula 10/2017 - 03/2009
2	Thromboembolism 10/2017 - 11/2007
2	Neutropenia 03/2009 - 01/2009
2	Adenocarcinoma 01/2009 - 07/2007
1	Nausea 02/2024
1	Vomiting 02/2024
1	Constipation 02/2024
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2021
1	Thrombotic Microangiopathies 07/2021
1	Atypical Hemolytic Uremic Syndrome 07/2021
1	Carcinosarcoma 09/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2020
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2020
1	Granulosa Cell Tumor 05/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Leiomyosarcoma 12/2018
1	Wounds and Injuries (Trauma) 10/2017
1	Second Primary Neoplasms (Neoplasms, Second) 11/2014
1	Obesity 11/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2014
1	Fallopian Tube Neoplasms 10/2013
1	Drug Hypersensitivity (Drug Allergy) 11/2012
1	Body Weight (Weight, Body) 12/2011
1	Carcinogenesis 04/2011

Drug/Important Bio-Agent (IBA)

29	Bevacizumab (Avastin)FDA Link 12/2022 - 03/2005
23	Paclitaxel (Taxol)FDA LinkGeneric 09/2023 - 09/2003
19	Cisplatin (Platino)FDA LinkGeneric 09/2023 - 09/2003
15	PlatinumIBA 12/2022 - 11/2004
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2021 - 03/2005
12	Carboplatin (JM8)FDA LinkGeneric 09/2023 - 09/2003
7	Topotecan (Hycamtin)FDA LinkGeneric 01/2019 - 01/2004
6	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2004
4	taxaneIBA 12/2022 - 01/2006
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2004 - 10/2003
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2023 - 09/2003
3	Monoclonal AntibodiesIBA 07/2021 - 12/2008
3	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 09/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2015 - 07/2007
3	liposomal doxorubicin (Doxil)FDA Link 12/2013 - 11/2007
2	AntigensIBA 12/2022 - 11/2016
2	Phosphotransferases (Kinase)IBA 11/2021 - 04/2011
2	LigandsIBA 07/2021 - 10/2019
2	Immune Checkpoint InhibitorsIBA 01/2020 - 10/2019
2	NivolumabIBA 01/2020 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2017
2	insulin receptor-related receptor (IRR)IBA 12/2010 - 10/2005
2	AgarIBA 12/2010 - 11/2002
2	Gemcitabine FDA Link 03/2009 - 11/2004
1	niraparibIBA 02/2024
1	paclitaxel poliglumex (XYOTAX)IBA 12/2022
1	Taxoids (Taxanes)IBA 12/2022
1	olaparibIBA 11/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2021
1	ceralasertibIBA 11/2021
1	Angiogenesis InhibitorsIBA 07/2021
1	eculizumab FDA Link 07/2021
1	IpilimumabIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Death Domain ReceptorsIBA 10/2019
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2019
1	Platinum Compounds (Compounds, Platinum)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	human ALK1-Fc fusion proteinIBA 01/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2017
1	Tumor Biomarkers (Tumor Markers)IBA 11/2017
1	CreatinineIBA 10/2017
1	Docetaxel (Taxotere)FDA Link 02/2015
1	1-dodecylpyridoxal (PLD)IBA 12/2013
1	EC145IBA 12/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2012
1	CytokinesIBA 12/2012
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 04/2011
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 04/2011

Therapy/Procedure

33	Drug Therapy (Chemotherapy) 09/2023 - 11/2002
26	Therapeutics 02/2024 - 07/2004
9	Radiotherapy 09/2020 - 03/2002
7	Lymph Node Excision (Lymph Node Dissection) 09/2020 - 09/2003
4	Hysterectomy 09/2020 - 09/2003
4	Adjuvant Chemotherapy 01/2020 - 12/2018
2	Neoadjuvant Therapy 11/2016 - 11/2012
2	Cytoreduction Surgical Procedures 11/2016 - 11/2016
2	Brachytherapy 01/2009 - 03/2002
1	Maintenance Chemotherapy 12/2022
1	Minimally Invasive Surgical Procedures 09/2020
1	Operative Time 01/2019
1	Colectomy 04/2014